Bill Text - HB476 (2015)

Amending the definition of "qualifying medical condition" in the therapeutic cannabis law.


Revision: July 7, 2015, midnight

CHAPTER 195

HB 476-FN – FINAL VERSION

4Mar2015… 0308h

05/14/2015 1485s

05/14/2015 1500s

2015 SESSION

15-0073

04/01

HOUSE BILL 476-FN

AN ACT amending the definition of “qualifying medical condition” in the therapeutic cannabis law.

SPONSORS: Rep. Stephen Schmidt, Carr 6; Rep. MacKay, Merr 14; Rep. McMahon, Rock 7; Rep. B. French, Merr 6; Sen. Reagan, Dist 17; Sen. Fuller Clark, Dist 21

COMMITTEE: Health, Human Services and Elderly Affairs

ANALYSIS

This bill adds several medical conditions to the definition of “qualifying medical condition” for the purpose of the law governing the use of cannabis for therapeutic purposes.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

4Mar2015… 0308h

05/14/2015 1485s

05/14/2015 1500s

15-0073

04/01

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Fifteen

AN ACT amending the definition of “qualifying medical condition” in the therapeutic cannabis law.

Be it Enacted by the Senate and House of Representatives in General Court convened:

195:1 Use of Cannabis for Therapeutic Purposes; Definitions. Amend RSA 126-X:1, IX(a) to read as follows:

(a) “Qualifying medical condition” means the presence of:

(1) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn’s disease, [agitation of Alzheimer’s disease,] multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson’s disease, Alzheimer’s disease, or one or more injuries that significantly interferes with daily activities as documented by the patient’s provider; and

(2) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer’s disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms.

195:2 Effective Date. This act shall take effect 60 days after its passage.

Approved: July 6, 2015

Effective Date: September 4, 2015

None